BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $32.73 million. The enterprise value is $2.45 million.

Market Cap	32.73M
Enterprise Value	2.45M

Important Dates

The last earnings date was Tuesday, March 10, 2026, after market close.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

BCTX has 7.25 million shares outstanding. The number of shares has increased by 784.70% in one year.

Current Share Class	7.25M
Shares Outstanding	7.25M
Shares Change (YoY)	+784.70%
Shares Change (QoQ)	+48.75%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	2.40%
Float	6.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.08
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.10

Current Ratio	10.10
Quick Ratio	9.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-831.19

Financial Efficiency

Return on equity (ROE) is -179.21% and return on invested capital (ROIC) is -114.89%.

Return on Equity (ROE)	-179.21%
Return on Assets (ROA)	-89.44%
Return on Invested Capital (ROIC)	-114.89%
Return on Capital Employed (ROCE)	-101.08%
Weighted Average Cost of Capital (WACC)	14.18%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.98% in the last 52 weeks. The beta is 1.81, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	-89.98%
50-Day Moving Average	4.53
200-Day Moving Average	10.89
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	243,392

Short Selling Information

The latest short interest is 103,944, so 1.43% of the outstanding shares have been sold short.

Short Interest	103,944
Short Previous Month	102,666
Short % of Shares Out	1.43%
Short % of Float	1.62%
Short Ratio (days to cover)	0.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.74M
Pretax Income	-29.96M
Net Income	-29.64M
EBITDA	-30.63M
EBIT	-30.74M
Earnings Per Share (EPS)	-$19.98

Balance Sheet

The company has $29.90 million in cash and n/a in debt, with a net cash position of $29.90 million or $4.12 per share.

Cash & Cash Equivalents	29.90M
Total Debt	n/a
Net Cash	29.90M
Net Cash Per Share	$4.12
Equity (Book Value)	30.21M
Book Value Per Share	4.26
Working Capital	28.99M

Cash Flow

Operating Cash Flow	-30.97M
Capital Expenditures	n/a
Depreciation & Amortization	106,627
Net Borrowing	n/a
Free Cash Flow	-30.97M
FCF Per Share	-$4.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-784.70%
Shareholder Yield	-784.70%
Earnings Yield	-90.56%
FCF Yield	-94.62%

Analyst Forecast

The average price target for BCTX is $40.00, which is 852.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.00
Price Target Difference	852.38%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-66.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1